Telum Therapeutics, a biotechnology company leveraging proprietary metagenomic datasets, synthetic biology and generative AI to develop novel antimicrobial therapies, has announced the successful comp...
In just 3.5 years, the company has grown its recurring revenue by 20x, reaching more than 20,000 customers, 1.5 million users, and automating billions of interactions. This achievement underscores the...
ESG reporting coverage expanded to 30 portfolio companies (+50% vs. 2024), all of which, within the scope of the report, measure their Scope 1–3 carbon footprint.
Founded in 2023, Dolfin helps RevOps, finance, and compensation teams design, manage, and adapt compensation plans without spreadsheets, complex implementations, or external consultants.
Fresh People, the Valencia-based technology company specialized in leadership and team management, has closed a €2.6 million funding round completed by Inveready, Archipiélago Next, Successful Fund...
The solution integrates advanced diagnostics, digital planning, and guided surgery into a single protocol, enabling clinical teams to carry out procedures with less variability, greater operational ef...
Iteria Biopharma has announced the closing of a Series Seed financing round of €5 million, contributed by Inveready, Xesgalicia and the founding partners. With this capital injection, the biotechnol...
Wikifarmer deploys artificial intelligence to automate price discovery, predict market movements, match buyers with verified suppliers, and manage end-to-end transactions—building the intelligence l...
Biotechnology company 53Biologics, specialized in the development and manufacturing of biologic drugs, has announced the closing of a strategic funding round led by European private equity firm Ren...
Inveready and Terram Capital have reached an agreement to develop a private debt platform through the company Terram Inveready Credit Partners, with the objective of launching a first fund of up to
Pharmacelera, a deep tech company applying Quantum Mechanics and Artificial Intelligence to revolutionize drug discovery based at the Barcelona Science Park (PCB-UB), has closed a €6 million investm...
Since its launch in 2021, Hospital Capilar has approached alopecia from a comprehensive medical perspective, offering clinical and surgical solutions based on scientific evidence, proven protocols, an...